Nations Pledge $1B For ACT-Accelerator, Funding Shortfall Remains; Leaders Call For More Global Cooperation On Vaccine Development, Distribution

Devex: World leaders pledge $1B for ACT-Accelerator
“A handful of global leaders pledged roughly $1 billion on Wednesday at a high-level event for the Access to COVID-19 Tools Accelerator, with the bulk of it going to vaccines. Several pharmaceutical companies also made commitments ensuring broad distribution of COVID-19 tools. However, around half of the funding had already been announced prior to the event, and still leaves the accelerator with a massive funding shortfall. The ACT-Accelerator, launched in April, is meant to help speed up the development of COVID-19 tools, and ensure their equitable distribution, with a particular focus on low- and middle-income countries. The accelerator is composed of four pillars — diagnostics, treatments, vaccines, and health systems connectors — and requires $38 billion in funding to deliver on its goals…” (Ravelo, 10/1).

Al Jazeera: COVID-19: U.N. calls for more support for ‘people’s vaccine’ plan
“António Guterres, the secretary-general of the United Nations, has again called for a ‘quantum leap in support’ for a global vaccine plan to contain the coronavirus pandemic, as the United Kingdom, Canada, Germany, and Sweden promised nearly $1bn in funds to support developing nations’ secure access to COVID-19 vaccines and treatments. … The initiative aims to deliver two billion vaccine doses by the end of 2021, 245 million treatments, and 500 million tests…” (10/1).

Devex: Q&A: Why Jerome Kim is ‘hopeful’ but cautious about distributing a COVID-19 vaccine
“The future prospects of an effective and safe COVID-19 vaccine — or, more likely, multiple vaccines — hung over the United Nations General Assembly’s opening 75th session last week. Experts like Jerome Kim, director general of the South Korea-based International Vaccine Institute, say that approving a vaccine is only the first of many complicated steps to ensuring that everyone across the world has access to one or more doses — and that they will actually take the vaccine, amid disinformation campaigns…” (Lieberman, 9/30).

DW: COVID-19: Global alliance comes to Africa’s rescue in vaccine rush
“In the race for a coronavirus vaccine, many African countries feel disadvantaged. An international vaccine coalition has pledged millions of doses for developing nations. But experts warn that Africa must do more…” (Schwikowski, 9/30).

U.N. News: Guterres urges more countries to step up and fund global COVID-19 vaccine effort
“…The Secretary-General called on developed countries — which have devoted many trillions of dollars to respond to the socio-economic impacts of the crisis in their own countries — to ‘invest a small fraction of that, to stop the spread of the disease everywhere’ …” (9/30).

U.S. News & World Report: Gates Foundation, Pharmaceutical Companies Join to Advance Coronavirus Vaccines
“The Bill and Melinda Gates Foundation has joined forces with 16 pharmaceutical companies to advance manufacturing and equitably distribute coronavirus vaccines. … Mark Suzman, CEO of the Gates Foundation, announced on Wednesday that 16 CEOs signed a communique stating their ‘commitments to help ensure equitable & effective global allocation of #COVID19 interventions’ …” (Lardieri, 9/30).

Xinhua: Singapore’s deputy PM calls for strengthening global cooperation on COVID-19 vaccines
“Singapore’s Deputy Prime Minister Heng Swee Keat called for strengthening international cooperation on vaccines, when he delivered a pre-recorded video message at the high-level United Nations General Assembly event on COVID-19 response on Wednesday evening…” (9/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.